Human Longevity, Inc. is a pioneering precision medicine and longevity company focused on enabling individuals to proactively take control of their health. Founded by Dr. Wei-Wu He, a genomic scientist who has worked with J. Craig Venter in the past, the company is focused on the development of precision medicine and the prevention of life-altering diseases. With the opening of its first clinic in San Diego, the company has since opened clinics in San Francisco and Beijing. Future clinics in various parts of the world have also been planned.

The company’s cutting-edge approach to precision medicine is focused on the development of individualized health baselines and risk profiles. This enables the company to develop individualized longevity programs. With the company’s cutting-edge diagnostics and genome sequencing, as well as its proactive health assessment and diagnostics, individuals can proactively work towards the development of optimal brain health, nutrition, and mobility.

With its focus on the prevention of diseases and the reduction of biological age, the company is revolutionizing the future of preventive medicine. With over 10,000 clients and a decade of research in the field of precision medicine, the company is enabling individuals to live longer, healthier, and more vibrant lives.

Offerings of Human Longevity, Inc.

Executive Health Program & $1 Million Cancer Prevention Pledge

Human Longevity offers an unmatched Executive Health program that utilizes cutting-edge diagnostic and preventative medicine to ensure long-term health and performance. The program is designed specifically for executives and high-performing professionals. The comprehensive and data-driven health evaluation will provide you with a thorough analysis of your health. This includes but is not limited to whole-genome sequencing, multicaner early detection blood tests, volumetric and whole-body MRI scans, and longitudinal biomarker analysis.

This multifaceted approach will enable the early detection of pre-symptomatic diseases such as heart disease and diabetes. The program is also underpinned by the $1 Million Cancer Prevention Pledge. This pledge represents the confidence that Human Longevity has in its science. As a participant of the program, if you are diagnosed with late-stage pancreatic, prostate, ovarian, or lung cancer, you will receive up to $1 million in clinical support, personalized oncology consultation, and treatment planning. The combination of preventative diagnostic medicine and financial security will provide you with peace of mind.

Comprehensive Multimodal Early Detection & Longevity Care

The company's strategy for addressing the challenge of longevity and preventive health care is to focus on the early detection of diseases as the most effective way of combating life-threatening diseases. The company achieves this through precision diagnostics, artificial intelligence-based screening, and imaging technologies. The Executive Health and 100+ Longevity programs enable individuals to understand their individual health baseline, improve their biological age, and address the root causes of diseases rather than the symptoms.

The $1 Million Cancer Prevention Pledge covers the most lethal forms of cancer, such as pancreatic cancer, prostate cancer, ovarian cancer, and lung cancer. By leveraging the benefits of multi-cancer early detection tests, genomics, and whole-body MRI scans, the company increases the survival rates of individuals in the early stages of cancer while minimizing the risk of false negative results. This enables individuals to have a dynamic and personalized health map while monitoring their symptoms and longitudinal data collection. This way, individuals can proactively engage in the management of their health and longevity while ensuring they remain active and healthy.

Personalized Longevity Programs & Data-Driven Preventive Care

Human Longevity offers highly personalized longevity services through its 100+ program, which is designed around detailed diagnostic data and ongoing clinical guidance. The company’s services include individualized care plans based on genomic analysis, cardiovascular assessments, and lifestyle evaluations for its 100+ program members. By tracking key biomarkers over time, the company’s clinical team offers personalized recommendations for nutrition, exercise, sleep, mobility, and cognitive health to help program members optimize their well-being and longevity.

Conventional health checkups only identify up to 15% of possible risks, but Human Longevity’s services go beyond the norm by providing advanced screenings and proactive management of health and wellness. Annual reviews of program members help to ensure that their progress is monitored and necessary adjustments are made to their plans to immediately address any risks detected. Through the application of personalized medicine, advanced diagnostics, and clinical guidance, Human Longevity empowers people to prevent disease and aging while maximizing their health and longevity.

The company’s services represent a holistic and data-driven approach to preventive medicine and health management for maximizing vitality and performance over long periods of time.

Dr. J. Craig Venter - Founder

Human Longevity empowers individuals to proactively manage their health, leveraging precision diagnostics, personalized longevity programs, and proactive care to extend vitality and prevent life-altering diseases.